Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 24.


Hobson, JJ ORCID: 0000-0003-2551-1774, Slater, R, Martin, P, Owen, A ORCID: 0000-0002-9819-7651 and Rannard, S ORCID: 0000-0002-6946-1097
(2016) Abstract. In: British Society for Nanomedicine Early Career Researcher Meeting, 2016-8-11 - 2016-8-12, Swansea.


Giardiello, M ORCID: 0000-0003-0560-4711, Liptrott, MJ, McDonald, TO ORCID: 0000-0002-9273-9173, Moss, D, Siccardi, M ORCID: 0000-0002-3539-7867, Martin, P, Smith, D, Gurjar, R, Rannard, SP ORCID: 0000-0002-6946-1097 and Owen, A ORCID: 0000-0002-9819-7651
(2016) Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies. Nature Communications, 7 (1). 13184-.


David, C ORCID: 0000-0001-8504-2354
(2016) Assessing the relationship between nanoparticle physicochemical characteristics and biological interactions; optimisation of in vitro techniques and protocols. PhD thesis, University of Liverpool.


McLean, KA, Kamarajah, SK, Chaudhry, D, Gujjuri, RR, Raubenheimer, K, Trout, I, AlAmeer, E, Creagh-Brown, B, Harrison, EM, Nepogodiev, D
et al (show 5526 more authors) (2021) Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic. BRITISH JOURNAL OF SURGERY, 108 (12). pp. 1448-1464.


David, CAW ORCID: 0000-0001-8504-2354, Owen, A ORCID: 0000-0002-9819-7651 and Liptrott, NJ ORCID: 0000-0002-5980-8966
(2016) Determining the relationship between nanoparticle characteristics and immunotoxicity: key challenges and approaches. NANOMEDICINE, 11 (11). pp. 1447-1464.


Neary, M ORCID: 0000-0002-4960-2139, Lamorde, M, Olagunju, A ORCID: 0000-0002-6588-5749, Darin, KM, Merry, C, Byakika-Kibwika, P, Back, DJ, Siccardi, M ORCID: 0000-0002-3539-7867, Owen, A ORCID: 0000-0002-9819-7651 and Scarsi, KK
(2017) The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine. CLINICAL PHARMACOLOGY & THERAPEUTICS, 102 (3). pp. 529-536.


Neary, M ORCID: 0000-0002-4960-2139, Box, H, Sharp, J, Tatham, L ORCID: 0000-0001-9448-8876, Curley, P ORCID: 0000-0003-4596-2708, Herriott, J, Kijak, E, Arshad, U ORCID: 0000-0003-1586-1885, Hobson, JJ ORCID: 0000-0003-2551-1774, Rajoli, Rkr ORCID: 0000-0002-6015-5712
et al (show 8 more authors) (2021) Evaluation of intranasal nafamostat or camostat for SARS-CoV-2 chemoprophylaxis in Syrian golden hamsters. [Preprint]


Rajoli, RKR ORCID: 0000-0002-6015-5712, Back, DJ, Rannard, S ORCID: 0000-0002-6946-1097, Meyers, CF, Flexner, C, Owen, A ORCID: 0000-0002-9819-7651 and Siccardi, M ORCID: 0000-0002-3539-7867
(2018) In Silico Dose Prediction for Long-Acting Rilpivirine and Cabotegravir Administration to Children and Adolescents. Clinical pharmacokinetics, 57 (02). pp. 255-266.


Rajoli, RKR ORCID: 0000-0002-6015-5712
(2017) Investigation of Long-acting Antiretroviral Nanoformulation Pharmacokinetics Using Experimental and Computational Methods. PhD thesis, University of Liverpool.


Swindells, S, Siccardi, M ORCID: 0000-0002-3539-7867, Barrett, SE, Olsen, DB, Grobler, JA, Podany, AT, Nuermberger, E, Kim, P, III, Barry CE, Owen, A ORCID: 0000-0002-9819-7651
et al (show 2 more authors) (2018) Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 22 (2). pp. 125-132.


Rajoli, RKR ORCID: 0000-0002-6015-5712, Back, D, Rannard, S ORCID: 0000-0002-6946-1097, Flexner, C, Owen, A ORCID: 0000-0002-9819-7651 and Siccardi, M ORCID: 0000-0002-3539-7867
(2016) Long-acting injectable formulations for children and adolescents using PBPK modelling. 11 August 2016, Swansea.


Tatham, L ORCID: 0000-0001-9448-8876, Savage, A, Rannard, S ORCID: 0000-0002-6946-1097 and Owen, A ORCID: 0000-0002-9819-7651
(2017) Maraviroc Solid Drug Nanoparticles with Improved Oral Pharmacokinetics. In: British Society for Nanomedicine, Queens University Belfast.


Tatham, L ORCID: 0000-0001-9448-8876, Savage, Alison C ORCID: 0000-0002-5312-9946, Dwyer, AB, Siccardi, M ORCID: 0000-0002-3539-7867, Scott, Trevor, Vourvahis, Manoli, Rannard, SP ORCID: 0000-0002-6946-1097 and Owen, A ORCID: 0000-0002-9819-7651
(2018) Maraviroc solid drug nanoparticles with improved oral pharmacokinetics. In: CROI, 2018-3-4 - 2018-3-7, Boston MA.


Rajoli, RKR ORCID: 0000-0002-6015-5712, Podany, AT, Moss, DM, Swindells, S, Flexner, C, Owen, A ORCID: 0000-0002-9819-7651 and Siccardi, M ORCID: 0000-0002-3539-7867
(2018) Modelling the long-acting administration of anti-tuberculosis agents using PBPK: a proof of concept study. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 22 (8). pp. 937-944.

Unspecified (2016) Nanoemulsions. .


Rajoli, RKR ORCID: 0000-0002-6015-5712, Back, D, Rannard, S ORCID: 0000-0002-6946-1097, Owen, A ORCID: 0000-0002-9819-7651 and Siccardi, M ORCID: 0000-0002-3539-7867
(2014) Optimisation of Intramuscular Sustained Release-Nano-Formulations Using In Silico Modelling. [Poster]


Rajoli, RKR ORCID: 0000-0002-6015-5712, Back, D, Rannard, S ORCID: 0000-0002-6946-1097, Owen, A ORCID: 0000-0002-9819-7651 and Siccardi, M ORCID: 0000-0002-3539-7867
(2016) Predicting Utility of Long-Acting Injectables in Paediatric Patients With PBPK Models. [Poster]


Rajoli, RKR ORCID: 0000-0002-6015-5712, Podany, A, Swindells, S, Flexner, C, Owen, A ORCID: 0000-0002-9819-7651 and Siccardi, M ORCID: 0000-0002-3539-7867
(2016) Simulation of long-acting administration of antituberculosis agents using pharmacokinetic modelling. 24 October 2016, Liverpool.


Tatham, L ORCID: 0000-0001-9448-8876, Ford, J, Rogers, H, Rannard, S ORCID: 0000-0002-6946-1097 and Owen, A ORCID: 0000-0002-9819-7651
(2016) Surface-Dependent Mechanism for Transcellular Permeation of Polymeric Nanoparticles Across Intestinal Monolayers. In: Controlled Release Society Annual Meeting & Exposition, 2016-7-17 - 2016-7-21, Seattle, Washington.


Andreopoulos, C ORCID: 0000-0003-2020-8215, Barbato, FCT, Barker, G, Barr, G, Beltrame, P, Berardi, V, Berry, T, Blondel, A, Boyd, S, Bravar, A
et al (show 68 more authors) (2016) TITUS: the Tokai Intermediate Tank for the Unoscillated Spectrum. Unknown. (Unpublished)


Rajoli, RKR ORCID: 0000-0002-6015-5712, Flexner, C, Owen, A ORCID: 0000-0002-9819-7651, Donnelly, R and Siccardi, M ORCID: 0000-0002-3539-7867
(2017) Transdermal delivery with microneedle patches using in silico modelling. 10 August 2017, Belfast.


Siccardi, M ORCID: 0000-0002-3539-7867, Dickinson, L ORCID: 0000-0001-5557-9396 and Owen, A ORCID: 0000-0002-9819-7651
(2016) Validation of computational approaches for antiretroviral dose optimization. Antimicrobial Agents and Chemotherapy, 60 (6). pp. 3838-3839.


Ahmed, WUR, Bhatia, S, McLean, KA, Khaw, R, Baker, D, Kamarajah, SK, Bell, S, Nepogodiev, D, Harrison, EM, Glasbey, JC
et al (show 4087 more authors) (2022) Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery. BJS OPEN, 6 (1). zrab150-.


Jackson, Akil ORCID: 0000-0002-4574-544X
(2017) The use of Pharmacokinetics to Optimise Dosing and Reformulation of Antiretrovirals for Treatment and Prevention. PhD thesis, University of Liverpool.

This list was generated on Sat Jan 27 00:41:27 2024 GMT.